Clinical Trial Update: Macular Edema Nepafenac vs. Difluprednate Uveitis Trial [Phase 4]

View source ↗

Summary

Phase 4 trial comparing nepafenac and difluprednate for uveitis-associated macular edema was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Uveitis

Drugs mentioned

• DIFLUPREDNATE (difluprednate)
• Nepafenac (nepafenac)

Snippet

Sponsor: University of California, San Francisco | Conditions: Uveitis, Macular Edema | Phase 4 | Status: TERMINATED